Delisting riskPopularity #3,258
HUMA · NASDAQ · Biotechnology

Humacyte (HUMA)

Commercializing Symvess while expanding its ATEV vessel platform.

$0.5900
After-hours close+0.01 (+1.18%)
At close$0.5831(−1.17%)